EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Influenza Antiviral Pharmacokinetic-Pharmacodynamic Relationships in Pregnancy, Infancy, and Early Childhood

Lindsey E Hastings, Edward P Acosta, David W Kimberlin iD

The Journal of Infectious Diseases · 2025

DOI: 10.1093/infdis/jiaf258 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Lindsey E Hastings und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Infectious Diseases, Department of Pediatrics, Heersink School of Medicine, University of Alabama at Birmingham. Hauptthemen laut MEDLINE: Antiviral Agents, Influenza, Human, Oseltamivir, Pregnancy Complications, Infectious. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 89 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Owing to its decades of use among patients of all ages and health conditions, oseltamivir has the most widely described pharmacokinetics (PK) and pharmacodynamics (PD) of all the modern influenza antivirals. Despite this, there remain numerous questions regarding optimal PK/PD parameters for oseltamivir and other neuraminidase inhibitors in populations at the highest risk for influenza-related complications including infants, young children, pregnant people, immunocompromised individuals, and those with altered clearance and drug distribution from critical illness, extracorporeal membrane oxygenation, and renal replacement therapies. Even less is known regarding the PK/PD of baloxavir—the first widely available cap-dependent endonuclease inhibitor—and the role that baloxavir may have alone and in combination with neuraminidase inhibitors for treating influenza in these populations. Support for further influenza antiviral PK and PD studies is needed to diversify and bolster our arsenal so that we may better protect and treat our most vulnerable patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsInfluenza, HumanOseltamivirPregnancy Complications, InfectiousHumansPregnancyFemaleInfantChild, PreschoolDibenzothiepinsPyridonesMorpholinesTriazinesThiepinsPyridinesInfant, NewbornNeuraminidase

Stichwörter der Autor:innen

antiviralsinfluenzapediatricspharmacokineticspregnancy

Substanzen

Antiviral AgentsOseltamivirbaloxavirDibenzothiepinsPyridonesMorpholinesTriazinesThiepinsPyridinesNeuraminidase

Autor:innen und Institutionen

  • Division of Pediatric Infectious Diseases, Department of Pediatrics, Heersink School of Medicine, University of Alabama at Birmingham.
  • Division of Infectious Diseases, Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham.
  • Division of Clinical Pharmacology, Department of Pharmacology and Toxicology, Heersink School of Medicine, University of Alabama at Birmingham.

ORCID-Profile: David W Kimberlin

Zitieren

APA

Hastings, L. E., Acosta, E. P., & Kimberlin, D. W. (2025). Influenza Antiviral Pharmacokinetic-Pharmacodynamic Relationships in Pregnancy, Infancy, and Early Childhood. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf258

Vancouver

Hastings LE, Acosta EP, Kimberlin DW. Influenza Antiviral Pharmacokinetic-Pharmacodynamic Relationships in Pregnancy, Infancy, and Early Childhood. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiaf258

BibTeX
@article{Hastings2025,
  author = {Hastings, Lindsey E and Acosta, Edward P and Kimberlin, David W},
  title = {Influenza Antiviral Pharmacokinetic-Pharmacodynamic Relationships in Pregnancy, Infancy, and Early Childhood},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  doi = {10.1093/infdis/jiaf258}
}
Kostenlos starten →